INDOBORAX (INDOBORAX): Acquisition / M&A

Strota Newsroom · session of 2026-08-20 · 20 Aug 15:31 · INDOBORAX stock page →

Indo Borax & Chemicals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Press… Historically, acquisition / m&a events have moved INDOBORAX-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Indo Borax & Chemicals has told the stock exchange it will acquire a 64.26% stake in Kronox Lab Sciences, according to an exchange filing on August 20. The company released a press release describing the deal, which marks the firm's second major M&A disclosure in a month — three earlier filings in July referenced an amalgamation or merger plan.

Acquisition and merger announcements across the Indian market carry a mixed record. Strota's historical data on this event type, drawn from 141 past instances, shows a win rate of 48.9% with a net edge of 0.213%. In plain terms, outcomes have been close to a coin flip on average, with only a marginal long-side advantage after prior acquisition filings.

At the time of the filing, Indo Borax traded at a price-to-earnings ratio of 26.74 and a price-to-book of 3.89, with return on equity standing at 13.9%. The company's market capitalisation was around 1,505 crore. It also paid a dividend yield of 2.13%. Institutional block deals on July 24 showed a mix of buys and sells from Microcurves Trading, Junomoneta Finsol, QE Securities, and HRTI — none of the trades exceeded 23 crore on either side.

The data establishes the catalyst clearly: a majority stake acquisition disclosed to the exchange. It does not confirm whether the deal will close on announced terms or what value it may unlock for existing shareholders. Past M&A events at this scale have, on average, produced near-flat outcomes, and any individual deal can diverge significantly from the base rate.

The catalyst

Indo Borax & Chemicals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Press Release - Indo Borax and Chemicals Limited to Acquire 64.26% Stake in Kronox Lab Sciences Limited". (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

INDOBORAX right now

P/E 26.74. Full INDOBORAX analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.